Last updated on August 2019

Iloprost in Acute Respiratory Distress Syndrome

Brief description of study

The patients will be randomized into one of two groups. Both groups will receive standard care as is state of the art. The intervention group will receive Iloprost nebulized as inhalative therapy.

Clinical Study Identifier: NCT03111212

Find a site near you

Start Over